CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (NASDAQ:XLRN), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases, today announced it will participate in several upcoming investor conferences.
Event: 2014 Deutsche Bank BioFEST
Date / Time: Monday, December 1, 2014 at 1:05 PM (EST)
Location: Four Seasons Hotel, Boston, Mass.
Event: Piper Jaffray 26th Annual Healthcare Conference
Date / Time: Tuesday, December 2, 2014 at 12:30 PM (EST)
Location: New York Palace, New York, N.Y.
Event: Oppenheimer 25th Annual Healthcare Conference
Date / Time: Wednesday, December 10, 2014 at 10:20 AM (EST)
Location: Crowne Plaza Hotel, New York, N.Y.
A live audio webcast for each event will be available on the “Events and Presentations” page in the Investors & Media section on the Company’s website (http://investor.acceleronpharma.com/events.cfm). A replay of the webcasts will also be available from Acceleron’s website.
Acceleron is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel protein therapeutics for cancer and rare diseases. The company is a leader in understanding the biology of the Transforming Growth Factor-Beta (TGF-β) protein superfamily, a large and diverse group of molecules that are key regulators in the growth and repair of tissues throughout the human body, and in targeting these pathways to develop important new medicines. Acceleron has built a highly productive R&D platform that has generated innovative clinical and preclinical protein therapeutic candidates with novel mechanisms of action. These protein therapeutic candidates have the potential to significantly improve clinical outcomes for patients with cancer and rare diseases.
For more information, please visit www.acceleronpharma.com.